Proteolytic Enzymes May Decrease The Risk Of Stroke

In our New York, NY office, Dr. John W. Phelts, D.C. sees many people who are at risk for cardiovascular disease.

High levels of platelets, fibrinogen and blood clotting factors can increase the chance of forming blood clots (thrombosis) and thereby increase the risk of stroke.  As recent study shows that a proteolytic enzyme called nattokinase, reduced blood clotting factors and fibrinogen significantly.  Another study showed that another proteolytic enzyme, bromelain, can reduce blood platelet count and aggregation.

We proudly serve the Manhattan area and are located in the center of the 10016, 10017, and 10018 zip codes.  Call us at 212-286-2012 to schedule an appointment.

References:
https://www.ncbi.nlm.nih.gov/pubmed/16308185

http://www.greenmedinfo.com/article/nattokinase-reduces-red-blood-cell-aggregation

https://www.ncbi.nlm.nih.gov/pubmed/19358933

Tags